Humacyte, Inc. (HUMA)
0.478
-0.02
(-4.40%)
USD |
NASDAQ |
Oct 06, 16:00
0.4843
+0.01
(+1.32%)
After-Hours: 20:00
Humacyte Price : 0.478 for Oct. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 0.501 | 0.5095 | 0.4724 | 0.478 | 4.281M |
| Oct 05, 2026 | 0.52 | 0.5223 | 0.4848 | 0.50 | 6.449M |
| Oct 02, 2026 | 0.5061 | 0.5343 | 0.5032 | 0.5215 | 5.395M |
| Oct 01, 2026 | 0.52 | 0.5283 | 0.5007 | 0.5029 | 2.995M |
| Sep 30, 2026 | 0.54 | 0.548 | 0.5104 | 0.5177 | 5.749M |
| Sep 29, 2026 | 0.5494 | 0.55 | 0.5312 | 0.5327 | 3.612M |
| Sep 28, 2026 | 0.55 | 0.5689 | 0.5316 | 0.5472 | 4.959M |
| Sep 25, 2026 | 0.56 | 0.5713 | 0.55 | 0.5573 | 2.620M |
| Sep 24, 2026 | 0.5599 | 0.5731 | 0.543 | 0.5687 | 2.835M |
| Sep 23, 2026 | 0.588 | 0.588 | 0.5556 | 0.5657 | 3.432M |
| Sep 22, 2026 | 0.5876 | 0.6079 | 0.5811 | 0.5828 | 3.470M |
| Sep 21, 2026 | 0.60 | 0.6099 | 0.575 | 0.59 | 3.406M |
| Sep 18, 2026 | 0.5699 | 0.6078 | 0.5699 | 0.5856 | 6.991M |
| Sep 17, 2026 | 0.5946 | 0.598 | 0.5652 | 0.5751 | 2.900M |
| Sep 16, 2026 | 0.5582 | 0.596 | 0.55 | 0.57 | 4.959M |
| Sep 15, 2026 | 0.56 | 0.5696 | 0.54 | 0.5516 | 3.212M |
| Sep 14, 2026 | 0.55 | 0.5749 | 0.55 | 0.561 | 3.165M |
| Sep 11, 2026 | 0.5759 | 0.5878 | 0.559 | 0.5676 | 2.265M |
| Sep 10, 2026 | 0.58 | 0.58 | 0.56 | 0.5671 | 2.665M |
| Sep 09, 2026 | 0.5905 | 0.6000 | 0.5751 | 0.579 | 2.925M |
| Sep 08, 2026 | 0.6095 | 0.6099 | 0.58 | 0.5949 | 2.402M |
| Sep 04, 2026 | 0.591 | 0.6101 | 0.5828 | 0.6049 | 2.965M |
| Sep 03, 2026 | 0.6076 | 0.6099 | 0.584 | 0.596 | 3.017M |
| Sep 02, 2026 | 0.5711 | 0.6111 | 0.57 | 0.5966 | 5.179M |
| Sep 01, 2026 | 0.598 | 0.6014 | 0.57 | 0.5704 | 16.54M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 402.60 |
| Altimmune, Inc. | 2.67 |
| Protalix Biotherapeutics, Inc. | 2.73 |
| Taysha Gene Therapies, Inc. | 4.39 |
| Agenus, Inc. | 7.49 |
Price Related Metrics
| PS Ratio | 43.78 |
| PEG Ratio | -0.1346 |
| Price to Book Value | 4.248 |
| Earnings Yield | -102.4% |
| Market Cap | 132.79M |
| PEGY Ratio | -0.1346 |